Ruth Hochberg, Author at Cancer Therapy Advisor

Ruth Hochberg

All articles by Ruth Hochberg

Addressing Unmet Medical Needs of Patients with Lung Cancer

Content Sponsored by the Janssen Pharmaceutical Companies of Johnson & Johnson When it comes to new therapies, patients with lung cancer face a significant global unmet medical need. Not only does lung cancer have the highest mortality rate of all cancers worldwide, it’s associated with significant heterogeneity – with many driver mechanisms that make it…

Advanced Treatment Options and Collaborative Care Brings Hope for Stage III Lung Cancer Patients

Content Sponsored by AstraZeneca Stage III lung cancer has historically been difficult to treat, and even more so for the approximate 80% of Stage III patients whose tumors are not removed with surgery. For these patients with unresected tumors, the five-year survival rate for patients who then undergo treatment with cCRT is approximately 32%. Thankfully,…

Next post in Industry Supported Education